DiscoverState of Digital Clinical Trials PodcastIs a Heavy Tech Burden the Price of Progress for Sites?
Is a Heavy Tech Burden the Price of Progress for Sites?

Is a Heavy Tech Burden the Price of Progress for Sites?

Update: 2024-10-31
Share

Description

Richard Young passes the torch to Manny Vazquez, our new podcast host, and shares his reflections before turning off his mic for the final time. Later, Manny is joined by renowned industry thinker and site leader Brad Hightower, owner of clinical research center Hightower Clinical in Oklahoma.




They discuss whether the growing tech burden is the price of progress for sites, plus tips on how sponsors can make sites’ lives easier. Brad also explains a few implications of the recent FDA draft guidance on DCTs and the upcoming site conference he helped to set up, ‘Save Our Sites’.



Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Is a Heavy Tech Burden the Price of Progress for Sites?

Is a Heavy Tech Burden the Price of Progress for Sites?

Veeva